Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)

Clinical trial NCT06889168 · RECRUITING

Trial details

NCT number: NCT06889168
Sponsor: Columbia University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphangioleiomyomatosis (LAM)Lymphangioleiomyomatosis

Start date: 2025-10-20
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.